European Congress of Clinical Microbiology and Infectious Diseases

Healio brings you the highlights from [FULL NAME OF MEETING]. Refer back to this page often for the latest news from [MEETING ABBREVIATION], perspectives and interviews with leading researchers and clinicians, and to review archives of past meetings.

‘Ultrasensitive’ C. difficile assay outperforms current testing options

May 6, 2018
Singulex’s Clarity C. diff toxins A/B assay could potentially be used as a standalone test for patients with Clostridium difficile
Meeting News

West Nile virus re-emerges in Greece

May 2, 2018
After a 2-year hiatus, West Nile virus has re-emerged in Greece, spreading to new territories, according to researchers from the University of Athens…
Meeting News

Data do not support piperacillin-tazobactam for drug-resistant BSIs

May 2, 2018
The risk for mortality was more than three times higher among patients with bloodstream infections caused by drug-resistant Escherichia coli or…
Meeting News

7-day antibiotic course noninferior to 14-day course for gram-negative bacteremia

April 30, 2018
For patients with gram-negative bacteremia, a 7-day regimen of antibiotic therapy was noninferior to the standard 14-day treatment, according to…
Meeting News

Iclaprim safe, potentially cost-effective for ABSSSIs

April 30, 2018
Motif Bio announced additional safety data from its REVIVE-2 trial of the investigational antibiotic iclaprim, showing that the treatment was…
Meeting News

Large C. auris outbreak in UK ICU linked to thermometers

April 26, 2018
Researchers linked one of the largest Candida auris outbreaks ever reported to thermometer use at a neurosciences ICU in the United Kingdom. …
Meeting News

Paratek Pharmaceuticals releases omadacycline topline results

April 25, 2018
Omadacycline is effective in treating acute bacterial skin and skin structure infections and community-acquired bacterial pneumonia, according to…
Meeting News

RESTORE-IMI 1: Phase 3 data support use of relebactam for CRE

April 23, 2018
Results of the phase 3 RESTORE-IMI 1 trial showed that relebactam was comparable to colistin when used in combination with imipenem/cilastatin in…
Meeting News

Omadacycline noninferior to Zyvox in treating ABSSSIs, including MRSA

April 28, 2017
Treatment of skin infections with the antibiotic omadacycline was noninferior to Zyvox in a phase 3 study, researchers said at the European Congress…
Meeting News

Drug-resistant bacteria in urine or stool increases risk for drug-resistant sepsis

April 27, 2017
Patients with urine or stool samples positive for drug-resistant bacteria are at an increased risk for developing bloodstream infections that also…

Meeting Calendar

The European Congress of Clinical Microbiology and Infectious Diseases

April 13, 2019 - April 16, 2019